Genetic screens for recessive lethal embryonic mutations and for adult phenotypes using the FLP/FRT system to generate genetic mosaics have formed the basis of much of our understanding of Drosophila developmental genetics. Although these techniques have facilitated the discovery of many genes involved in development, what is not possible using any of the techniques available today is to efficiently screen for synthetic lethality or synthetic interactions between mutations with recessive phenotypes.
We aim to establish a set of new genetic tools that will make it possible to efficiently screen for synthetic interactions in Drosophila. Screening for synthetic interactions requires the use of two independent genetic recombination systems to generate single and double mutant clones within one animal. This proposal aims at establishing a second site-specific recombination system, the fC31-integrase/att system, in Drosophila. Combined with the FLP/FRT system, the fC31-integrase/att system will perform efficient screens for synthetic interactions. We will test this system in flies using mutations in the components of the Insulin Receptor (InR) signaling pathway (PTEN, InR, and dAM). These tools will have broad applications and will lead to the discovery of novel genetic interactions in Drosophila that could not have been detected using currently available methods. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21GM071487-02
Application #
6922070
Study Section
Development - 1 Study Section (DEV)
Program Officer
Portnoy, Matthew
Project Start
2004-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2005
Total Cost
$188,750
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Biochemistry
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030